Adenoma growth stimulation by the trans-10, cis-12 isomer of conjugated linoleic acid (CLA) is associated with changes in mucosal NF-κB and cyclin D1 protein levels in the Min mouse

Journal of Nutrition

Volumn 133, Issue 6, 2003, Pages 1943-1948

  Rajakangas, Johanna ^c   Basu, Samar ^a   Salminen, Irma ^b   Mutanen, Marja ^c  

^a UPPSALA UNIVERSITY   (Sweden)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c NONE

Author keywords

Colon cancer; Conjugated linoleic acid; Min mouse

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; BETA CATENIN; CYCLIN D1; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LINOLEIC ACID; SYNAPTOTAGMIN; TUMOR PROMOTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER GROWTH; CIS TRANS ISOMERISM; COLON ADENOMA; COLON CARCINOGENESIS; CONTROLLED STUDY; LIPID PEROXIDATION; MOUSE; NONHUMAN; TUMOR VOLUME;

ANIMALIA;

EID: 0037638993     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/133.6.1943     Document Type: Article

References (49)

1. Ha, Y. L., Storkson, J. & Pariza, M. W. (1990) Inhibition of benzo(a)pyrene-induced mouse forestomach neoplasia by conjugated dienoic derivates of linoleic acid. Cancer Res. 50: 1097-1101.
2. Ip, C., Chin, S. F., Scimeca, J. A. & Pariza, M. W. (1991) Mammary cancer prevention by conjugated dienoic derivates of linoleic acid. Cancer Res. 51: 6118-6124.
3. Ip, C., Singh, M., Thompson, H. J. & Scimeca, J. A. (1994) Conjugated linoleic acid suppresses mammary carcinogenesis and proliferative activity of the mammary gland in the rat. Cancer Res. 54: 1212-1215.
4. Belury, M. A., Nickel, K. P., Bird, C. E. & Wu, Y. (1996) Dietary conjugated linoleic acid modulation of phorbol ester skin tumor promotion. Nutr. Cancer 26: 149-157.
5. Shultz, T. D., Chew, B. P., Seaman, W. R. & Luedecke, L. O. (1992) Inhibitory effect of conjugated dienoic derivates of linoleic acid and β-carotene on the in vitro growth of human cancer cells. Cancer Lett 63: 125-133.
6. Ip, M. M., Masso-Welch, P. A., Shoemaker, S. F., Shea-Eaton, W. K. & Ip, C. (1999) Conjugated linoleic acid inhibits proliferation and induces apoptosis of normal rat mammary epithelial cells in primary culture. Exp. Cell Res. 250: 22-34.
7. Park, Y., Allen, K. G. D. & Shultz, T. D. (2000) Modulation of MCF-7 breast cancer cell signal transduction by linoleic acid and conjugated linoleic acid in culture. Anticancer Res. 20: 669-676.
8. Ip, C., Scimeca, J. A. & Thompson, H. (1995) Effect of timing and duration of dietary conjugated linoleic acid on mammary cancer prevention. Nutr. Cancer 24: 241-247.
9. Ip, C., Briggs, S. P., Haegele, A. D., Thompson, H. J., Storkson, J. & Scimeca, J. A. (1996) The efficacy of conjugated linoleic acid in mammary cancer prevention is independent of the level or type of fat in the diet. Carcinogenesis 17: 1045-1050.
10. Ip, C., Jiang, C., Thompson, H. J. & Scimeca, J. A. (1997) Retention of conjugated linoleic acid in the mammary gland is associated with tumor inhibition during the post-initiation phase of carcinogenesis. Carcinogenesis 18: 755-759.
11. Aro, A., Männistö, S., Salminen, I., Ovaskainen, M.-L., Kataja, V. & Uusitupa, M. (2000) Inverse association between dietary and serum conjugated linoleic acid and risk of breast cancer in postmenopausal women. Nutr. Cancer 38: 151-157.
12. Yang, H., Stuart G. R., Glickman B. W. & de Boer, J. G. (2001) Modulation of 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine induced mutation in the caecum and colon of Big Blue rats by conjugated linoleic acid and 1, 2-dithiole-3-thione. Nutr. Cancer 39: 259-266.
13. Ealy, K. N., El-Sohemy, A. & Archer, M. C. (2001) Conjugated linoleic acid does not inhibit development of aberrant crypt foci in colons of male Sprague-Dawley rats. Nutr. Cancer 41: 104-106.
14. Hansen Petrik, M. B., McEntee, M. F., Johnson, B. T., Obukowicz, M. G. & Whelean, J. (2000) Highly unsaturated (n-3) fatty acids, but not α-linolenic, conjugated linoleic or γ-linoleic acids, reduce tumorigenesis in ApcMin mice. J. Nutr. 130: 2434-2443.
15. Rajakangas, J., Turpeinen, A. M., Salminen, I. & Mutanen, M. (2002) Effects of conjugated linoleic acid (CLA) on adenoma formation in the ApcMin-mouse. In: Nutrition and Lifestyle: Opportunities for Cancer Prevention (Riboli E. & Lambert R., ed.), pp. 405-406. IARC Scientific Publications No. 156, IARC, Lyon, France.
16. Kinzler, K. W. & Vogelstein, B. (1996) Lessons from hereditary colorectal cancer. Cell 87: 159-170.
17. Rubinfeld, B., Albert, I., Porfiri, E., Fiol, C., Munemitsu, S. & Polakis, P. (1996) Binding of GSK3β to the APC-β-catenin complex and regulation of complex assembly. Science (Washington, DC) 272: 1023-1026.
18. Kawahara, K., Moshita, T., Nakamura, T., Hamada, F., Toyshima, K. & Akiyamata, T. (2000) Down regulation of beta-catenin by the colorectal tumor suppressor APC requires association with Axin and beta-catenin. J. Biol. Chem. 275: 8369-8374.
19. Behrens, J., Kreies von, J. P., Kühl, M., Bruhn, L., Wedlich, D., Grosschedl, R. & Birchmeier, W. (1996) Functional interaction of β-catenin with the transcription factor LEF-1. Nature (Lond.) 382: 638-642.
20. He, T-C., Sparks, A. B., Rago, C., Hermeking, H., Zawel, L., Costa da, L. T., Morin, P. J., Vogelstein, B. & Kinzler, K. W. (1998) Identification of c-MYC as a target of the APC pathway. Science (Washington, DC) 281: 1509-1512.
21. Tetsu, O. & McCormick, F. (1999) β-catenin regulaten expression of cyclin D1 in colon carcinoma cells. Nature (Lond.) 398: 422-426.
22. He, T-C., Chan, T. A., Vogelstein, B. & Kinzler, K. W. (1999) PPARδ is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell 99: 335-345.
23. Sellin, J. H., Umar, S., Xiao, J. & Morris, A. P. (2001) Increased β-catenin expression and nuclear translocation accompany cellular hyperproliferation in vivo. Cancer Res. 61: 2899-2906.
24. Roh, H., Green, D. W., Boswell, C. B., Pippin, J. A. & Drebin, J. A. (2001) Suppression of β-catenin inhibits the neoplastic growth of APC-mutant colon cancer cells. Cancer Res. 61: 6563-6568.
25. Basu, S., Riserus, U., Turpeinen, A. & Vessby, B. (2000) Conjugated linoleic acid induces lipid peroxidation in men with abdominal obesity. Clin. Sci. (Lond.) 99: 511-516.
26. Basu, S., Smedman, A. & Vessby, B. (2000) Conjugated linoleic acid induces lipid peroxidation in humans. FEBS Lett. 468: 33-36.
27. Morrow, J. D. & Roberts, L. J., II, (1996) The isoprostanes. Current knowledge and directions of future research. Biochem. Pharmacol. 51: 1-9.
28. 2α: an index for oxidative injury via free radical catalysed lipid peroxidation. Prostaglandinds Leukot. Essent. Fatty Acids 58: 319-325.
29. Schönberg, S. & Krokan, H. E. (1995) The inhibitory effect of conjugated dienoic derivates (CLA) of linoleic acid on the growth of human tumor cell lines is in part due to increased lipid peroxidation. Anticancer Res. 15: 1241-1246.
30. O'Shea, M., Stanton, C. & Devery, R. (1999) Antioxidant enzyme defence responses of human MCF-7 and SW480 cancer cells to conjugated linoleic acid. Anticancer Res. 19: 1953-1960.
31. Karin, M., Cao, Y., Greten, F. R. & Li, Z-W. (2002) NF-κB in cancer: from innocent bystander to major culprit. Nat. Rev. Cancer 2: 301-310.
32. Pahl, H. L. (1999) Activators and target genes of Rel/NF-κB transcription factors. Oncogene 18: 6853-6866.
33. Yamamoto, K., Arkawa, T., Ueda, N. & Yamamoto, S. (1995) Transcriptional roles of nuclear factor κB and nuclear factor interleukin-6 in the tumor necrosis factor α-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells. J. Biol. Chem. 270: 31315-31320.
34. Guttridge, D. C., Albanese, C., Reuther, J. Y., Pestell, R. G. & Baldwin A. S., Jr. (1999) NF-κB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol. Cell. Biol. 19: 5785-5799.
35. Tsujii, M., Kawano, S., Tsuji, S., Sawaoka, H., Hori, M. & DuBois, R. N. (1998) Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 93: 705-716.
36. 2 in human colon cancer cells. Cancer Res. 58: 362-366.
37. Arber, N., Hibshoosh, H., Moss, S. F., Sutter, T., Zhang, Y., Begg, M., Wang, S., Weinstein, I. B. & Holt, P. R. (1996) Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis. Gastroenterology 110: 669-674.
38. Reeves, P. G., Nielsen, F. H. & Fahey, G. C. (1993) AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J. Nutr. 123: 1939-1951.
39. Mutanen, M., Pajari, A-M. & Oikarinen, S. I. (2000) Beef induces and rye bran prevents the formation of intestinal polyps in ApcMin mice: relation to β-catenin and PKC isozymes. Carcinogenesis 21: 1167-1173.
40. Folch, J., Lees, M. & Sloan-Stanley, G. H. (1957) A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226: 497-507.
41. Stoffel, W., Chu, F. & Ahrens, E. H., Jr. (1959) Analysis of long-chain fatty acids by gas liquid chromatography. Anal. Chem. 31: 307-308.
42. Matsui, K., Fine, A., Zhu, B., Marshak-Rothstein, A. & Ju, S.-T. (1998) Identification of two NF-κB sites in mouse CD95 ligand (Fas ligand) promoter: functional analysis in T cell hybridoma. J. Immunol. 161: 3469-3473.
43. Chan, H., Bartos, D. P. & Owen-Schaub, L. B. (1999) Activation-dependent transcriptional regulation of the human fas promoter requires NF-κB p50-p65 recruitment. Mol. Cell. Biol. 19: 2098-2108.
44. Wu, H. & Lozano, G. (1994) NF-κB activation of p53. J. Biol. Chem. 269: 20067-20074.
45. Stark, L. A., Din, F.V.N., Zwacka, R. M. & Dunlop, M. G. (2001) Aspirin-induced activation of the NF-κB signaling pathway: a novel mechanism for aspirin-mediated apoptosis in colon cancer cells. FASEB J. 15: 1273-1275.
46. Cadoret, A., Bertrand, F., Baron-Delage, S., Lévy, P., Curtois, G., Gespach, C., Capeau, J. & Cherqui, G. (1997) Down-regulation of NF-κB activity and NF-κB p65 subunit expression by ras and polynoma middle T oncogenes in human colonic Caco-2 cells. Oncogene 14: 1589-1600.
47. Zang, T., Nanney, L. B., Luongo, C., Lamps, L., Heppner, K. L., DuBois, R. N. & Beauchamp, R. D. (1997) Concurrent overexpression of cyclin D1 and cyclin-dependent kinase 4 (Cdk4) in intestinal adenomas from multiple intestinal neoplasia (Min) mice and human familial adenomatous polyposis patients. Cancer Res. 57: 169-175.
48. ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J. Biol. Chem. 270: 23589-23597.
49. Williams, C. S., Luongo, C., Radhika, A., Zhang, T., Lamps, L. W., Nanney, L. B., Beuchamp, R. D. & DuBois, R. N. (1996) Elevated cyclooxygenase-2 levels in Min mouse adenomas. Gastroenterology 111: 1134-1140.